GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PAO Group Inc (OTCPK:PAOG) » Definitions » EV-to-EBITDA

PAO Group (PAO Group) EV-to-EBITDA : (As of Jun. 05, 2024)


View and export this data going back to 2004. Start your Free Trial

What is PAO Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PAO Group's enterprise value is $0.76 Mil. PAO Group does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PAO Group's EV-to-EBITDA at this moment.

The historical rank and industry rank for PAO Group's EV-to-EBITDA or its related term are showing as below:

PAOG's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.64
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), PAO Group's stock price is $0.0004. PAO Group does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PAO Group's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


PAO Group EV-to-EBITDA Historical Data

The historical data trend for PAO Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PAO Group EV-to-EBITDA Chart

PAO Group Annual Data
Trend
EV-to-EBITDA

PAO Group Quarterly Data
EV-to-EBITDA

Competitive Comparison of PAO Group's EV-to-EBITDA

For the Medical Care Facilities subindustry, PAO Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PAO Group's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PAO Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PAO Group's EV-to-EBITDA falls into.



PAO Group EV-to-EBITDA Calculation

PAO Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.764/
=


PAO Group  (OTCPK:PAOG) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PAO Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0004/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


PAO Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PAO Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PAO Group (PAO Group) Business Description

Traded in Other Exchanges
N/A
Address
11424 Frances Street, Suite B, Omaha, NE, USA, 68144
PAO Group Inc is a United States-based holding company. It seeks to develop, acquire, partner, or participate in, companies and concepts in the development and launch of alternative medicine clinics focused on non-traditional patient care solutions. The range of treatment solutions includes cannabis, acupuncture, chiropractic, biofeedback, and other solutions depending on patient needs. The group primarily operates in the United States of America.